Prelude Capital Management’s Johnson & Johnson JNJ Stock Holding History

Prelude Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,300	Closed	-$564K	–	2109
2020 Q1	$564K	Sell	4,300 -8,200	-66%	-$1.16M	0.04%	304
2019 Q4	$1.82M	Sell	12,500 -12,500	-50%	-$1.7M	0.07%	238
2019 Q3	$3.23M	Buy	+25,000	New	+$3.29M	0.15%	94
2019 Q2	–	Sell	-22,500	Closed	-$3.15M	–	1900
2019 Q1	$3.15M	Buy	+22,500	New	+$3.01M	0.18%	104

Other funds holding JNJ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Prelude Capital Management's JNJ Position: Q1 2026 in Review

Prelude Capital Management sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 2,154 shares — an estimated $446K sold.

Prelude Capital Management first reported a position in JNJ in Q2 2013 and held it in 33 quarters. The position peaked at $3.58M in Q3 2024. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

Prelude Capital Management reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
Prelude Capital Management sold 2,154 Johnson & Johnson shares in Q1 2026, an estimated $446K.
Prelude Capital Management first reported a position in Johnson & Johnson in Q2 2013 and held it in 33 quarters.
Prelude Capital Management's Johnson & Johnson position peaked at $3.58M in Q3 2024.
4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.